(Total Views: 601)
Posted On: 01/01/2022 6:15:28 PM
Post# of 153977
NASH question:
It was openly stated that CYDY would aggressively seek a partner with NASH if the results are worthy. Given that possibility what could that potentially do for the PPS?
I’ve seen some articles about other biotechs with good phase two data and their PPS rose substantially.
Even if it were only a few dollars it would make those 200 millions shares worth much more to fund future trials etc.
I’m curious what others think about what will be the first catalyst?
Could the Brazil trial be filling up? We just haven’t gotten a PR yet?
It was openly stated that CYDY would aggressively seek a partner with NASH if the results are worthy. Given that possibility what could that potentially do for the PPS?
I’ve seen some articles about other biotechs with good phase two data and their PPS rose substantially.
Even if it were only a few dollars it would make those 200 millions shares worth much more to fund future trials etc.
I’m curious what others think about what will be the first catalyst?
Could the Brazil trial be filling up? We just haven’t gotten a PR yet?
(2)
(0)
